As of 2025-04-22, the Fair Value of Bright Minds Biosciences Inc (DRUG.CN) is -0.76 CAD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 44.45 CAD, the upside of Bright Minds Biosciences Inc is -101.71%.
With the market price of 44.45 CAD and our fair value calculation, Bright Minds Biosciences Inc (DRUG.CN) is not a good investment. Investing in DRUG.CN stocks now will result in a potential loss of 101.71%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 5Y Avg | |
| Net income | -0.48 | -8.65 | -14.96 | -7.37 | -2.80 | -6.85 |
| YoY growth | -510.24% | -1,700.82% | -72.99% | 50.74% | 61.99% | -434.26% |
| Market Cap (mil) | 312.93 |
| P/E | |
| Forward P/E |
| EPS | -0.15 |
| Avg earnings growth rate | -434.26% |
| TTM earnings | -1.07 |